imipenem


Also found in: Thesaurus, Medical, Wikipedia.
Related to imipenem: Meropenem, vancomycin
Translations

imipenem

n imipenem m
References in periodicals archive ?
The US Food and Drug Administration (FDA) on Wednesday cleared the marketing of the antibacterial drug Recarbrio (imipenem, cilastatin and relebactam), for adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) under its Qualified Infectious Disease Product (QIDP) designation & Priority Review designations.
THURSDAY, July 18, 2019 (HealthDay News) -- The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, the U.S.
WEDNESDAY, July 17, 2019 (HealthDay News) -- The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, the U.S.
Isolates showing resistance to carbapenems (Imipenem 10ug) were screened for presence of MBL by the IMP-EDTA double disk-diffusion test (DDDT).
(1) Carbapenem drugs such as meropenem, imipenem and ertapenem are used for treatment of infections due to drug-resistant K.
The study developed statistical methods to predict phenotypic resistance from resistance genes for various combinations of the four bacterial species and the antibiotics gentamicin, tobramycin, ciprofloxacin, levofloxacin, trimethoprim-sulfamethoxazole, ertapenem, imipenem, cefazolin, cefepime, cefotaxime, ceftazidime, ceftriaxone, ampicillin, piperacillin and aztreonam.
Susceptibility to imipenem and meropenem was tested by disk difusion and broth microdilution test, and interpreted according to the CLSI criteria (21-23).
This study is aimed to evaluate the effect of imipenem, amikacin and cefixime on swarming of P.
Similarly, 25 were resistant to Imipenem, in which 12 (16%) isolates were positive for MBL production.
The following antibiotics were tested for gram-negative bacilli: Imipenem (10 mcg), Meropenem (10 mcg), piperacillin/ tazobactam (100/10 mcg), ceftriaxone (30 mcg), cefotaxime (30 mcg), cefixime (5 mcg), cefepime (30 mcg), Cefoperazone (75 mcg), ceftazidime (30 mcg), gentamicin (10 mcg), amikacin (30 mcg), ciprofloxacin (5 mcg), ofloxacin (5 mcg), norfloxacin (10 mcg), ticarcillin/clavulanic acid (75/10 mcg), nitrofurantoin (300 mcg), trimethoprim/sulfamethoxazole (co-trimoxazole) (1.25/23.75 mcg), tetracycline (30 mcg) and moxifloxacin (5 mcg).